Italfarmaco

Italfarmaco, based in Milan, Italy, is a pharmaceutical company. Italfarmaco is a pharmaceutical group that researches, develops and manufactures medicines, with a particular focus on rare diseases. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing givinostat and Givinostat in myeloproliferative neoplasms. The largest, NCT06093672 (Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera), plans to enrol 220 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.